It had been showed that CXCR2 ligands, such as C-X-C motif chemokine (CXCL)1–3 and CXCL5–8 released from various cancer type drive neutrophil recruitment from circulation and chemotaxis toward the tumor (Sharma et al., 2013). This evidence concerns the gene CXCR2 and neoplasm.